Carolyn J. Bowen

Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects

Aimee K. Bence, Eric B. Anderson, Maqbool Halepota et al. · Investigational New Drugs · 2004 · 119 citations

Healthy Subjects, Oral Gw572016, Pharmacology +5

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose

Kyle D. Holen, Chandra P. Belani, George Wilding et al. · Cancer Chemotherapy and Pharmacology · 2010 · 71 citations · Full text

Biochemistry, Medicine, Biologic Effects +5

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers

Alicia J. Allred, Carolyn J. Bowen, Jung Wook Park et al. · British Journal of Clinical Pharmacology · 2011 · 71 citations · Full text

Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects

Deborah A. Smith, Kevin M. Koch, Nikita Arya et al. · British Journal of Clinical Pharmacology · 2009 · 60 citations · Full text

Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human Subjects

Yanli Deng, Armina Madatian, Mary Beth Wire et al. · Drug Metabolism and Disposition · 2011 · 54 citations